CVS vs PETS
CVS Health Corp. and Petmed Express, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CVS | PETS |
|---|---|---|
| Revenue | $402.1B | $179.0M |
| Net income | $1.8B | $-57.3M |
| Gross margin | 45.0% | 28.1% |
| Net margin | 0.4% | −32.0% |
| Return on equity | 2.3% | −100.4% |
| Diluted EPS | $1.39 | −$2.74 |
| Dividend / share | $2.66 | $0.00 |
| Payout ratio | 192.1% | −0.0% |
| Free cash flow | $7.8B | $-33.0M |
| Equity | $75.2B | $28.9M |
| Net debt / equity | 0.69× | — |
| Current ratio | 0.84× | 0.84× |
| Revenue CAGR 5y | 8.4% | −10.0% |
| Profit CAGR 5y | −24.4% | — |
CVS bills 2245.9× the revenue of PETS, and PETS closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | CVS | PETS |
|---|---|---|
| FY2025 | $402.1B | $179.0M |
| FY2024 | $372.8B | $227.0M |
| FY2023 | $357.8B | $274.1M |
| FY2022 | $322.5B | $247.6M |
| FY2021 | $292.1B | $272.3M |
| FY2020 | $268.7B | $303.6M |
| FY2019 | $256.8B | $284.1M |
| FY2018 | $194.6B | $283.4M |
| FY2017 | $184.8B | $273.8M |
| FY2016 | $177.5B | $249.2M |
Net income by year
Bottom line
| Fiscal year | CVS | PETS |
|---|---|---|
| FY2025 | $1.8B | $-57.3M |
| FY2024 | $4.6B | $-6.3M |
| FY2023 | $8.3B | $-7.5M |
| FY2022 | $4.3B | $5.1M |
| FY2021 | $8.0B | $18.7M |
| FY2020 | $7.2B | $23.9M |
| FY2019 | $6.6B | $25.9M |
| FY2018 | $-594.0M | $37.7M |
| FY2017 | $6.6B | $37.3M |
| FY2016 | $5.3B | $23.8M |
Advertisement
AdSense · Rectangle 336×280
More in this industry